Shenwei Pharmaceutical (02877.HK) achieved a revenue of 2.415 billion yuan in the first three quarters, a year-on-year decrease of 16.3%.
Wisdom Financial News APP, Shandong Pharmaceutical (02877.HK) announced that the unaudited management accounts of the company and its subsidiaries for the nine months ended September 30, 2025, showed a revenue of RMB 2.415 billion, a decrease of 16.3% compared to the same period in 2024, which are:
Latest
3 m ago

